A novel combination of an investigational intravesical drug delivery system designed to provide sustained release of gemcitabine into the bladder (Gem-iDRS, Inlexzo) and systemic treatment with the ...
Q4 2025 Earnings Call March 18, 2026 8:30 AM EDTCompany ParticipantsMarvin Slosman - President, CEO & DirectorMichael Lawless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results